Login / Signup

Aerosol SARS-CoV-2 in hospitals and long-term care homes during the COVID-19 pandemic.

Gary MallachSamantha B KasloffThomas A KovesiAnand KumarRyan KulkaJay KrishnanBenoit RobertMichaeline McGuintySophia den Otter-MooreBashour YazjiTodd Cutts
Published in: PloS one (2021)
In total, 138 samples were collected from 99 rooms. RNA samples were positive in 9.1% (6/66) of samples obtained with the UPAS 2.5μm samplers, 13.5% (7/52) with the UPAS 10μm samplers, and 10.0% (2/20) samples obtained with the Coriolis samplers. Culturable virus was not recovered in any samples. Viral RNA was detected in 15.1% of the rooms sampled. There was no significant difference in viral RNA recovery between the different room locations or samplers. Method development experiments indicated minimal loss of SARS-CoV-2 viability via the personal air sampler operation.
Keyphrases
  • sars cov
  • long term care
  • respiratory syndrome coronavirus
  • healthcare